Stay up-to-date with all the local and international news from the HARTMANN GROUP.

Company news

August 02, 2019

HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019

The HARTMANN GROUP, one of the leading international suppliers of medical and hygiene products, increased sales revenues by 3.7% to EUR 1.075 billion in the first half of 2019. All segments generated higher sales. The Wound Management segment has developed particularly dynamically. The Wound Management segment was an additional growth factor. With innovative wound care treatment concepts, we were able to exceed the average sales growth achieved by the HARTMANN GROUP. EBIT declined overall to EUR 53.4 million (previous year: EUR 61.1 million), a development attributable in particular to the anticipated rise in the price of important raw materials and exchange rate trend.
May 10,2019

HARTMANN GROUP starts the 2019 financial year with a 4% rise in sales

In the first three months of 2019, the HARTMANN GROUP, one of the leading international suppliers of medical and hygiene products, increased its sales revenues by 4.0% to EUR 536.4 million. The key growth drivers were the Wound Management segment and the CMC and KNEIPP brands that are included in the Other Group Activities segment. EBIT amounted to EUR 30.6 million which was virtually the same last year’s figure of EUR 31.3 million. As expected, the higher prices of raw materials in particular had an adverse impact.
Oct 10, 2018

Britta Fuenfstueck appointed as new CEO of the HARTMANN GROUP

The Supervisory Board of the HARTMANN GROUP today announced the appointment of Britta Fuenfstueck as the company’s new Chief Executive Officer and Chair of HARTMANN’s Management Board. Fuenfstueck will succeed Andreas Joehle, who has been in office since 2013 and announced last year his plans to step down due to personal reasons. She will join the Management Board of HARTMANN on November 1, 2018 and will succeed Joehle as CEO on January 1, 2019.
May 4 2018

HARTMANN starts its anniversary year 2018 with strong growth

The HARTMANN GROUP made a positive start in its anniversary year, 2018. Propelled by innovative product solutions and LINDOR's sales in the incontinence management segment, the Group's sales revenues rose to €516.0 million in the first quarter of 2018, an increase of 2.3 percent compared to the previous year. Without the negative impact of adverse exchange rates in America and Asia due to the strength of the euro, the rise in sales would have amounted to around 4 percent. Earnings before interest and taxes (EBIT) were in line with expectations at €31.3 million.
Aug 09 2017

HARTMANN GROUP is investing in the future

Heidenheim/ Germany, August 9, 2017. In the first six months of 2017, the HARTMANN GROUP, a leading international supplier of medical and healthcare products, achieved sales revenues of EUR 1,006.8 million and exceeded the prior-year figure by 3.4%, thus passing the one billion mark for the first time ever within a half-year period. As expected, growth in the second quarter was more restrained, due to among other things, changes in product range, connected with pending market launches within the Incontinence Management segment. Because of investments in growth, as reflected in particular in the greater expenditure for sales and marketing and the higher cost of raw materials and expenses for regulatory issues, the earnings before interest and taxes (EBIT) were slightly lower at EUR 65.4 million (prior year: EUR 68.6 million). The Group's consolidated net income of EUR 45.4 million is nevertheless at the same level as last year (EUR 45.3 million).
Press Contacts
For more information, please contact our Corporate Communications team:
+49-7321-36 1313